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Abstract Primary simian varicella virus (SVV) infection in
non-human primates causes varicella, after which the virus
becomes latent in ganglionic neurons and reactivates to cause
zoster. The host response in ganglia during establishment of
latency is ill-defined. Ganglia from five African green mon-
keys (AGMs) obtained at 9, 13, and 20 days post-intratracheal
SVV inoculation (dpi) were analyzed by ex vivo flow cytom-
etry, immunohistochemistry, and in situ hybridization.
Ganglia at 13 and 20 dpi exhibited mild inflammation.
Immune infiltrates consisted mostly of CD8dim and CD8bright
memory T cells, some of which expressed granzyme B, and
fewer CD11c+ and CD68+ cells. Chemoattractant CXCL10
transcripts were expressed in neurons and infiltrating inflam-
matory cells but did not co-localize with SVV open reading
frame 63 (ORF63) RNA expression. Satellite glial cells
expressed increased levels of activation markers CD68 and
MHC class II at 13 and 20 dpi compared to those at 9 dpi.
Overall, local immune responses emerged as viral DNA load
in ganglia declined, suggesting that intra-ganglionic immunity
contributes to restricting SVV replication.
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Introduction
Varicella-zoster virus (VZV) is a neurotropic human
alphaherpesvirus. Primary infection causes varicella (chicken
pox), after which VZV becomes latent in ganglionic neurons;
reactivation leads to zoster (shingles) (Arvin and Gilden
2013). Virus-specific immunity is essential for uncomplicated
recovery from varicella and zoster (Arvin and Gilden 2013).
While the magnitude of systemic VZV-specific T cell re-
sponses is known to be inversely correlated with the severity
of varicella and zoster in immunocompetent individuals
(Arvin et al. 1986; Malavige et al. 2008; Weinberg et al.
2009), VZV-specific immune responses in infected tissues
have not been studied in detail (Vukmanovic-Stejic et al.
2013, 2015; Zak-Prelich et al. 2003). Zoster is associated with
profound inflammation of ganglia, mainly involving infiltrat-
ing T cells that are likely to inhibit local VZV replication and
spread (Gowrishankar et al. 2010; Steain et al. 2014).
However, the immune response in human ganglia after prima-
ry VZV infection has not been studied in detail (Berg et al.
1969; Cheatham et al. 1956; Nagashima et al. 1975).
Due to the highly restricted host tropism of VZV, virus and
host factors involved in VZV disease cannot be studied in
animal models (Arvin and Gilden 2013). Simian varicella vi-
rus (SVV) infection of non-human primates parallels VZV
infection in humans (Mahalingam and Gilden 2007;
Ouwendijk and Verjans 2015). Primary SVV infection causes
varicella, after which virus becomes latent in ganglionic neu-
rons along the entire neuraxis and reactivates to cause zoster
(Dueland et al. 1992; Kennedy et al. 2004; Mahalingam et al.
1991, 2007). As in human VZV infection, SVV-specific adap-
tive immune responses are pivotal in limiting disease severity
of both primary and recurrent infections, and virus reactiva-
tion induces a transient influx of non-cytolytic T cells in gan-
glia (Haberthur et al. 2011; Kolappaswamy et al. 2007;
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Ouwendijk et al. 2013a). Furthermore, depletion of CD4+ T
cells, but not B cells or CD8+ T cells, prevents establishment
of SVV latency, suggest ing the involvement of
intra-ganglionic immune responses (Meyer et al. 2013).
Here, we aimed to characterize the immune response in gan-
glia after primary SVV infection of African green monkeys
(AGMs) using both wild-type SVV (SVV-wt) and




Cells and tissues were collected from AGM intratracheally
inoculated with the wild-type deltaherpesvirus strain of SVV
(SVV-wt) (n = 2) or a recombinant virus, based on the
deltaherpesvirus strain, that expresses enhanced green fluores-
cent protein in infected cells (SVV-EGFP) (n=3) and eutha-
nized at 9 (n=2), 13 (n=2), and 20 days post-infection (dpi)
(n= 1), as described (Ouwendijk et al. 2013b) (Table 1).
SVV-EGFP was created by inserting a Rous sarcoma virus
promoter-EGFP gene cassette between the putative
polyadenylation site of SVV open reading frame 66
(ORF66) and the putative TATA box for ORF67, resulting in
ectopic expression of EGFP in infected cells (Mahalingam et
al. 1998). AGMs were housed, and experiments were per-
formed in compliance with European guidelines (EU
Directive on Animal Testing 86/609/EEC) and Dutch legisla-
tion. The protocol was approved by the independent animal
experimentation ethical review committee DCC (Driebergen,
the Netherlands; Erasmus MC permit number EMC2374).
Flow cytometry
Individual ganglia from two SVV-EGFP-infected AGMs, eu-
thanized at 9 dpi (animal 294; n=5 ganglia) and 13 dpi (animal
273; n=3 ganglia) (Table 1), were dissociated into single-cell
suspensions as described (Verjans et al. 2007). Briefly, ganglia
were finely diced, enzymatically dissociated using Liberase
Blendzyme 3 (0.2 U/ml) (Roche), and filtered through a
70-μm pore size mesh. Single-cell suspensions of individual
ganglia and peripheral blood mononuclear cells were stained
using fluorochrome-conjugated mouse monoclonal antibodies
(mAbs), CD3APC-Cy7 (clone SP34-2), CD4AmCyan (L200),
CD8PerCp (SK1), CD14PE (M5E2), CD20PE-Cy7 (L27), and
HLA-DRPacificBlue (L243) (all from BD Biosciences).
Single-cell suspensions of ganglia were also stained with a
mAb specific for CD45APC (MB4-6D6; Miltenyi Biotec) to
distinguish leukocytes from non-leukocytes. Tcell subsets were
identified using mAbs specific for CD3APC-Cy7 (SP34-2),
CD4PacificBlue (L200), CD8AmCyan (SK1), CD28APC (28.2),
and CD95PerCp (DX2) (all from BD Biosciences).
Fluorescence was detected on a FACS Canto II and analyzed
using FlowJo software (Tree Star Inc.). Gating strategy for
identification of viable cells, leukocytes, and leukocyte subsets
is defined in the legend of Fig. 1. On average, 6.5×102 and
5.3×102 viable leukocytes were analyzed at 9 and 13 dpi.
Immunohistochemistry
Trigeminal, cervical, thoracic, lumbar, and sacral ganglia
w e r e f i x e d i n 4 % p a r a f o r m a l d e h y d e i n
phosphate-buffered saline (PBS), paraffin-embedded, and
4-μm sections were analyzed by immunohistochemistry
(IHC). We examined multiple ganglia (total n=72 ganglia)
from both SVV-wt- and SVV-EGFP-infected AGMs at
9 dpi [animals 269 (SVV-wt) and 294 (SVV-EGFP)],
13 dpi [animals 279 (SVV-wt) and 273 (SVV-EGFP)],
and 20 dpi [animal 283 (SVV-EGFP)] (Table 1), and each
IHC staining was performed on two to three sections per
ganglion at different levels of the tissue. Tissue sections
were deparaffinized, rehydrated, and subjected to
heat-induced antigen retrieval in citrate buffer (10 mM,
pH 6.0); blocked with 10 % normal goat or rabbit serum
diluted in PBS; and incubated overnight with primary an-
tibodies diluted in PBS containing 0.1 % BSA
(Ouwendijk et al. 2013b). Primary antibodies included
mAbs directed against human CD3 (clone F7.2.38;
Dako), CD11c (NCL-L-CD11c-563; Novocastra), CD20
(L26; Dako), CD68 (KP1; Dako), granzyme B (GrB-7;
Dako), MHC class II (CR3/43; Dako), Ki67 (MIB-1;
Dako), rabbit anti-human S100B (EP1576Y; GeneTex),
and rabbit polyclonal antibodies directed against SVV nu-
cleocapsid proteins (Dueland et al. 1992). As isotype con-
trols, sections were incubated with the respective mouse
isotype antibody (Dako) or rabbit pre-immune serum. For
IHC s t a i n i ng , s e c t i on s we r e i n cuba t ed w i t h
biotin-conjugated secondary goat anti-mouse or goat
anti-rabbit IgG antibodies followed by horseradish
peroxidase-conjugated streptavidin (Dako). Staining was
visualized using 3-amino-9-ethylcarbazole (AEC;
Sigma-Aldrich), and sections were counterstained with he-
matoxylin (Sigma-Aldrich). For immunofluorescence
staining, sections were incubated with secondary Alexa
Fluor 488 (AF488)-conjugated goat anti-rabbit Ig,
A F 5 9 4 - c o n j u g a t e d g o a t a n t i - m o u s e I g G ,
AF488-conjuga ted goa t an t i -mouse IgG2a , o r
AF594-conjugated goat anti-mouse IgG1 antibodies and
mounted in Prolong Gold Antifade Reagent with 4′,
6-diamidino-2-phenylindole (DAPI) (Invitrogen).
Sections were analyzed on a Zeiss LSM700 confocal
laser scanning microscope (Zeiss) and using ZEN 2010
software (Zeiss) to adjust brightness and contrast.
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In situ hybridization
We examined multiple ganglia (n = 32) along the entire
neuraxis, from both SVV-wt- and SVV-EGFP-infected
AGMs at 9 dpi [animals 269 (SVV-wt) and 294
(SVV-EGFP)], 13 dpi [animals 279 (SVV-wt) and 273
(SVV-EGFP)], and 20 dpi [animal 283 (SVV-EGFP)] (Table
1) by in situ hybridization (ISH), according to the manufac-
turer’s instructions (Advanced Cell Diagnostics). Briefly,
deparaffinized 5-μm tissue sections were incubated with
probes against SVV ORF63, CXCL10, ubiquitin C (positive
control), and the bacterial DapB gene (negative control) using
the RNAscope 2.0 Kit Red (Advanced Cell Diagnostics), as
described (Ouwendijk et al. 2013a). Signal was visualized
using FastRed as a substrate, and slides were counterstained
with hematoxylin and mounted in Ecomount (Biocare
Medical). Each ISH staining was performed on one to two
sections at different levels of the tissue.
Quantification of IHC and ISH staining
The numbers of cells expressing CD3, CD11c, CD20, and
CD68 [CD68high macrophages, excluding satellite glial cells
(SGCs)] protein and CXCL10 transcripts were determined at
200X magnification. The number of granzyme B-expressing
cells was determined at 400X magnification. The number of
neurons was quantified by scanning the slides using the
Nanozoomer 2.0 HT (Hamamatsu) and subsequent analysis
by Adobe Photoshop CS6 (Adobe). Overall, 72 ganglia were
Table 1 Characteristics of tissues used to analyze the cell types, nucleic acids, and proteins in ganglia of African green monkeys after primary SVV
infection
Animal Virus Dpi Levela Symbolb SVV DNA loadc Number of ganglia (neurons) analyzed by
Flow cytometry IHC ISH
269 SVV-wt 9 TG ● 3.90 × 103 – – –
Cervical ■ 1.40 × 104 – 9 (2,257) –
Thoracic ▲ 1.21 × 104 – 5 (1,248) 2 (1,273)
Lumbar ▼ 1.16 × 106 – – –
Sacral ♦ 4.65 × 104 – 2 (1,161) 4 (1,973)
294 SVV-EGFP 9 TG ○ 4.64 × 102 – 1 (368) –
Cervical □ 2.80 × 102 1 – –
Thoracic Δ 1.55 × 102 1 3 (325) –
Lumbar ∇ 1.53 × 102 2 – –
Sacral ◊ 5.69 × 102 1 3 (566) 3 (1,156)
279 SVV-wt 13 TG ● 1.38 × 103 – 1 (664) –
Cervical ■ 4.88 × 102 – 5 (2,417) 3 (1,063)
Thoracic ▲ 5.76 × 102 – 6 (625) –
Lumbar ▼ 3.55 × 102 – 2 (242) –
Sacral ♦ 2.37 × 102 – 3 (1,598) 4 (1,884)
273 SVV-EGFP 13 TG ○ 1.87 × 101 – 1 (368) –
Cervical □ 7.22 × 100 1 6 (1,398) –
Thoracic Δ 4.68 × 100 – 2 (782) –
Lumbar ∇ 4.25 × 100 1 4 (1,970) 3 (1,381)
Sacral ◊ 0.38 × 100 1 6 (3,506) 6 (2,470)
283 SVV-EGFP 20 TG ○ 5.46 × 100 – 1 (552) –
Cervical □ 1.89 × 101 – 4 (1,368) 4 (1,152)
Thoracic Δ 4.03 × 100 – – –
Lumbar ∇ 2.61 × 101 – 3 (872) –
Sacral ◊ 5.46 × 101 – 5 (2,631) 3 (1,967)
Total number of ganglia (neurons) 8 72 (24,918) 32 (14,319)
Dpi days post-infection, IHC immunohistochemistry, ISH in situ hybridization, – not done
a Anatomical level of the neuraxis from which ganglia were obtained. TG trigeminal ganglia
b Symbol used in Figs. 1, 2, 3, and 4 to denote anatomical location of ganglia analyzed
c Copies of SVV ORF21 DNA per 105 cells, determined as described (Ouwendijk et al. 2013b)
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examined [14.4±4.7 (mean± standard deviation)] per animal,
encompassing 24,918 neurons (Table 1).
Statistical analyses
Data were assessed for statistical differences using the
Student’s t test, and correlations were determined using
Pearson’s correlation test. Statistical analyses were conducted
using GraphPad Prism 5 (GraphPad Software, Inc.), and p
values <0.05 were considered statistically significant.
Results
Previously, we inoculated five AGMs intratracheally with
SVV-wt (n=2; animals 269 and 279) and SVV-EGFP (n=3;
animals 294, 273, and 283) to identify the cell types and route
involved in primary SVVinfection (Table 1) (Ouwendijk et al.
2013b). Although SVV-EGFP was reported to be not attenu-
ated in vitro and in vivo (Mahalingam et al. 1998, 2001), the
virus showed reduced replication and severity of disease com-
pared to SVV-wt in AGM (Ouwendijk et al. 2013b).
Nevertheless, the pathogenesis of SVV-EGFP paralleled that
of SVV-wt in AGM (Ouwendijk et al. 2013b). Ganglia were
obtained at 9 (n=2), 13 (n=2), and 20 dpi (n=1) (Table 1). In
AGM infected with SVV-wt or SVV-EGFP, we demonstrated
that SVV nucleocapsid antigen was more abundant in ganglia
at 9 dpi compared to 13 and 20 dpi (Ouwendijk et al. 2013b).
SVV DNA load in ganglia was significantly higher in
SVV-wt- compared to SVV-EGFP-infected AGMs, peaking
at 9 dpi and decreasing thereafter (Ouwendijk et al. 2013b)
(Table 1), as might be expected during the establishment of
latency (Messaoudi et al. 2009; Ou et al. 2007; Ouwendijk et
al. 2012). Herein, we extended these findings by characteriz-
ing the immune response in the ganglia obtained after primary
SVV infection.
Infiltration of CD8dim and CD8bright memory T cells
into ganglia after primary SVV infection
To investigate the inflammatory response in ganglia, single-cell
suspensions of ganglia from two SVV-EGFP-infected AGMs
obtained at 9 dpi (animal 294; n=5 ganglia) and 13 dpi (animal
273; n=3 ganglia) were analyzed by ex vivo flow cytometry
(Table 1 and Fig. 1a). Significantly higher frequencies of
CD45+ leukocytes were found in ganglia at 13 dpi compared
to 9 dpi (p=0.006) (Fig. 1b). At both times, CD45+ leukocytes
were predominantly T cells (Fig. 1c). Unlike humans, AGMs
contain three distinct T cell populations identifiable based on
differential expressions of CD4 and CD8α, CD4+ T cells
( C D 3 + C D 4 + C D 8 α d i m ) , C D 8 d i m T c e l l s
(CD3 +CD4 −CD8α d i m ) , a n d CD8 b r i g h t T c e l l s
(CD3+CD4−CD8αhigh) (Beaumier et al. 2009). CD4+ and
CD8dim T cells are interrelated dynamic populations
Fig. 1 Ex vivo flow cytometry of ganglia after primary SVV infection of
African green monkeys. Single-cell suspensions were prepared from
eight ganglia obtained from two SVV-EGFP-infected AGMs at 9 days
post-infection (dpi) (animal 294; n= 5 ganglia) and 13 dpi (animal 273;
n= 3 ganglia) and analyzed by flow cytometry (Table 1). a–cViable cells
were selected based on forward scatter (FSC) and sideward scatter (SSC)
properties, gated on CD45+ leukocytes, and defined as CD3+ T cells,
CD20+HLA-DR+ B cells, and CD3–CD14+HLA-DR+ monocytes. d T
cell subsets were defined as CD4+CD8α− BCD4+ T cells,^
CD4−CD8αdim BCD8dim T cells,^ and CD4−CD8αbright BCD8bright T
cells.^ e T cells were categorized as naïve (CD28+CD95−), central mem-
ory (CM; CD28+CD95+), or effector memory (EM; CD28−CD95+) T
cells. Horizontal bars indicate mean values. Open symbols refer to gan-
glia obtained at 9 dpi and indicate anatomical level of the neuraxis from
which ganglia were obtained (Table 1). Filled stars refer to individual
cervical, lumbar, and sacral ganglia obtained at 13 dpi, from which the
original anatomic location of each sample was not annotated in the flow
cytometry assay. f, g Comparison of T cell subsets in paired ganglia and
peripheral blood (PB) specimens. b–e Student’s t test was used for statis-
tical analysis. **p< 0.01, ***p< 0.001
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collectively equivalent to human CD4Tcells, while CD8bright T
cells correspond to human CD8 T cells (Beaumier et al. 2009).
Additionally, non-human primate T cells can be classified as
naïve, central memory (CM), and effector memory (EM) pop-
ulations based on differential expressions of CD28 and CD95
(Beaumier et al. 2009). Whereas CM T cells recirculate be-
tween lymphoid tissues and peripheral blood, EM Tcells home
to peripheral tissues to exert their effector function (Picker et al.
1990; Pitcher et al. 2002). Ganglia obtained at 13 dpi contained
significantly higher frequencies of CD8dim (p<0.001) and CM
(p=0.002) Tcells compared to those obtained at 9 dpi (Fig. 1d,
e). Analyses of paired peripheral blood (PB) and ganglionic
single-cell suspensions showed similar frequencies of CD4+,
CD8dim, and CD8bright Tcells in PB and ganglia at 9 dpi, where-
as ganglia were enriched for CD8dim Tcells at 13 dpi compared
to PB (Fig. 1f). Most ganglionic T cells had an EM phenotype
at 9 dpi (Fig. 1g), consistent with their function and findings in
human trigeminal ganglia (Verjans et al. 2007). High frequen-
cies of both EM and CM T cells were detected in ganglia at
13 dpi (Fig. 1g). Overall, primary SVV-EGFP infection was
associated with increased frequencies of leukocytes, mainly
CD8dim and CD8bright T cells of CM and EM phenotypes, in
ganglia at 13 dpi compared to 9 dpi.
Transient increases in CD3+ T cells and CD11c+ myeloid
cells in ganglia
To determine the location of inflammatory cells within ganglia
after primary SVV infection, we analyzed ganglia (n=72)
obtained at 9, 13, and 20 dpi in AGM infected with either
SVV-wt (n=2) or SVV-EGFP (n=3) for the presence of im-
mune cells expressing CD3 (T cells), CD20 (B cells), CD11c
(dendritic cells and monocytes/macrophages), and CD68
(macrophages and SGC) by IHC (Table 1). Ganglia from both
SVV-wt- and SVV-EGFP-infected AGMs contained similar
numbers of immune infiltrates, which peaked at 13 dpi and
were composed mostly of CD3+ T cells, with lower numbers
of CD11c+ myeloid cells and CD68+ monocytes/macrophages
(Fig. 2a; data not shown). These inflammatory cells were dis-
persed throughout the tissue, but occasionally, clusters of T
cells surrounding neurons were observed in both SVV-wt- and
SVV-EGFP-infected animals (data not shown). Analysis of
the numbers of cells expressing CD3, CD20, CD11c, and
CD68 (CD68high macrophages), normalized to the total num-
ber of neurons in the same section, showed that primary SVV
infection was associated with a transient significant increase in
the relative number of CD3+ (p=0.02) cells and CD11c+ my-
eloid (p=0.01) cells at 13 dpi compared to 9 dpi (Fig. 2b).
Numbers of CD3+ and CD11c+ cells tended to decrease at
20 dpi. The relative number of CD3+ cells and CD11c+ cells
was not significantly different between SVV-wt- and
SVV-EGFP-infected animals at 9 dpi (p=0.92 and p=0.32,
respectively) and 13 dpi (p=0.46 and p=0.41, respectively).
Notably, occasional CD3+, CD11c+, and CD68+ cells were
found adjacent to neurons expressing SVV nucleocapsid an-
tigens in both SVV-wt- and SVV-EGFP-infected AGMs at
13 dpi (Fig. 2c).
Ganglion-infiltrating T cells express granzyme B
To determine whether Tcells infiltrating ganglia were exposed
to antigen and are actively involved in local immune re-
sponses, we analyzed expression of the cytotoxic T cell mark-
er granzyme B (GrB) in ganglia of AGM infected with either
SVV-wt (n=2) or SVV-EGFP (n=3) by IHC. Occasional
GrB+ cells were detected in ganglia obtained at 9 dpi.
Greater numbers of GrB+ cells were present in most ganglia
obtained at 13 and 20 dpi, although the increase was not sta-
tistically significant (p = 0.22 and p = 0.65, respectively)
(Fig. 3a). GrB+ cells tended to be more abundant in
SVV-wt- compared to SVV-EGFP-infected AGMs at 13 dpi
(p=0.07) (Fig. 3a). Some GrB+ cells were localized close to
SVVnucleocapsid-positive neurons at 13 dpi in both SVV-wt-
and SVV-EGFP-infected AGMs (Fig. 3b). The relative num-
bers of CD3+ and GrB+ cells in ganglia correlated significant-
ly (r=0.53, p=0.01) (Fig. 3c). Most GrB+ cells were also
CD3+ in adjacent sections (data not shown) and in sections
immunofluorescently double stained for CD3 and GrB at 9,
13, and 20 dpi (Fig. 3d), irrespective of the virus used for
inoculation. Overall, the ratio of GrB+/CD3+ cells did not
differ at 9 dpi (mean ± standard error of the mean, 0.09
±0.36), 13 dpi (0.07±0.20), and 20 dpi (0.07±0.27), suggest-
ing that although more T cells infiltrated ganglia at 13 and
20 dpi, enrichment for antigen-reactive GrB+ T cells had not
occurred.
Correlation between numbers of CXCL10+ neurons
and GrB+ T cells
Although earlier studies indicated that chemokine CXCL10
mediates infiltration of T cells into ganglia after VZV and
SVV reactivation (Ouwendijk et al. 2013a; Steain et al.
2011), its potential role in primary infection has not been
studied. ISH analysis revealed CXCL10 transcripts in both
neurons and non-neuronal cells (resident SGC and/or infiltrat-
ing leukocytes) in ganglia (n=32) obtained from SVV-wt-
(n=2) and SVV-EGFP-infected AGMs (n=3) at 9, 13, and
20 dpi (Fig. 4a and Table 1). Significantly, more neurons
expressed CXCL10 transcripts at 13 dpi compared to 9 dpi
(p=0.02) (Fig. 4b). Furthermore, more non-neuronal cells
expressed CXCL10 transcripts at 13 dpi compared to 20 dpi
(p = 0.04) (Fig. 4b). The numbers of neuronal and
non-neuronal cells expressing CXCL10 were significantly
higher in SVV-wt- compared to SVV-EGFP-infected AGMs
at 13 dpi (p=0.002 and p=0.02, respectively). Combining
data from SVV-wt- and SVV-EGFP-infected animals
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demonstrated that the number of CXCL10+ neurons correlat-
ed significantly with the number of GrB+ T cells (r=0.70,
p=0.03) and tended to correlate with the total number of
infiltrating T cells (r=0.60, p=0.08) (Fig. 4c, d). In contrast,
the number of non-neuronal cells expressing CXCL10 did not
correlate with either the number of GrB+ or CD3+ cells
(r=0.46, p=0.21 and r=0.38, p=0.30, respectively) (data
not shown).
To determine if CXCL10 expression co-localized with
SVV-infected neurons, adjacent ganglion sections were
stained for CXCL10 transcripts and SVV ORF63 RNA by
ISH. SVV ORF63 is expressed at high levels during lytic
infection in vitro and in vivo but also in neurons during laten-
cy (Deitch et al. 2005; Messaoudi et al. 2009; Meyer et al.
2011; Ouwendijk et al. 2012). Most ORF63 transcripts were
localized in the (peri-)nuclear region of neurons of both
SVV-wt- and SVV-EGFP-infected AGMs at 9, 13, and
20 dpi (Fig. 4e). Few non-neuronal cells expressed ORF63
RNA (Fig. 4e), and more ORF63+ non-neuronal cells tended
to be present at 9 dpi compared to 13 and 20 dpi (p=0.06 and
p=0.09, respectively) (Fig. 4f). Whereas SVV nucleocapsid
antigenwas more abundant at 9 dpi compared to 13 and 20 dpi
(Ouwendijk et al. 2013b), similar frequencies of SVV
ORF63+ neurons were observed at 9 dpi (mean± standard
error of the mean, 2.8±0.67 %), 13 dpi (4.5±1.60 %), and
20 dpi (4.2±1.0 %) (Fig. 4g). The frequency of ORF63+ neu-
ron was higher at 13 dpi (p=0.004) but not at 9 dpi (p=0.53)
in SVV-wt- compared to SVV-EGFP-infected AGMs. The
number of neurons expressing ORF63 transcripts correlated
significantly with the number of CXCL10+ neurons (r=0.63,
p<0.001) (Fig. 4h) but not non-neuronal cells expressing
CXCL10 (r= 0.23, p= 0.27) (data not shown). However,
ISH analysis of adjacent sections of ganglia showed that
CXCL10 and ORF63 were expressed by distinct populations
of neurons, which was not different between SVV-wt-and
SVV-EGFP-infected AGMs (Fig. 4i), suggesting that SVV
infection did not directly induce CXCL10 expression.
Expressions of activation and proliferation markers
in ganglia
Acute herpes simplex virus (HSV) infections in mice induce
activation and proliferation of SGC (Elson et al. 2003; Pereira
et al. 1994). Human SGC phenotypically resemble microglia,
the antigen-presenting cells of the central nervous system, which
express CD68 and MHC-II molecules constitutively (Hanani
2005; van Velzen et al. 2009). Tissue sections of 72 ganglia,
obtained from SVV-wt- (n=2) or SVV-EGFP-infected AGMs
(n=3) at different dpi, were stained for the activation markers
Fig. 2 Immunohistochemical analyses of immune cells in ganglia after
primary SVV infection of African green monkeys. Immunohistochemical
(IHC) staining of ganglia (n= 72 ganglia from five animals) at 9, 13, and
20 days post-infection (dpi) for CD3, CD20, CD11c, and CD68. 3-
Amino-9-ethylcarbazole (AEC) was used as a substrate (red), and nuclei
were counterstained with hematoxylin (blue). a Representative IHC im-
ages are shown for 9 dpi [CD3, cervical ganglion from animal 269 (SVV-
wt); CD20, CD11c, and CD68, thoracic ganglia from animal 294 (SVV-
EGFP)], 13 dpi [CD3, CD20, and CD11c, sacral ganglia from animal 273
(SVV-EGFP); CD68, sacral ganglion from animal 279 (SVV-wt)], and
20 dpi [sacral ganglia from animal 283 (SVV-EGFP)] (see Table 1). Mag-
nification ×400. Arrows indicate examples of CD3+ cells, CD11c+ cells,
and CD68+ macrophages. b Ratio of numbers of CD3+, CD20+, CD11c+,
and CD68+ cells normalized to the number of neurons in the same tissue
section at different dpi. Horizontal bars indicate mean values. Open and
filled symbols refer to ganglia from individual animals infected with SVV-
EGFP (n= 3) or SVV-wt (n = 2), respectively (Table 1). The Student’s t
test was used for statistical analysis. *p < 0.05. c Immunofluorescent dou-
ble staining for SVV nucleocapsid antigen (green) and CD3, CD68, or
CD11c (red). Representative images of ganglia obtained from animal 279
(SVV-wt) at 13 dpi are shown. Nuclei were counterstained with DAPI.
Magnification ×400 and ×1.5 digital zoom. Arrows indicate examples of
CD3+, CD11c+, and CD68+ cells. Arrowheads indicate SVV+ neurons
Fig. 3 Detection of granzyme B+ cells in ganglia after primary SVV
infection of African green monkeys. a Ratio of numbers of granzyme B
(GrB)+ cells normalized to the number of neurons in the same tissue
section (n= 72 ganglia from five animals; see Table 1) at different days
post-inoculation (dpi). Horizontal bars indicate mean values. b Repre-
sentative confocal microscopy image of a ganglion obtained from a SVV-
wt-infected AGM (animal 279) at 13 dpi stained for SVV nucleocapsid
antigen (green) and GrB (red). Arrow indicates a GrB+ cell, and
arrowheads indicate SVV+ neurons. c Scatter plot of the ratio of CD3+
cells/neurons versus the ratio of GrB+ cells/neurons in consecutive sec-
tions. d Representative confocal microscopy image of a ganglion obtain-
ed from a SVV-wt-infected AGM (animal 279) at 13 dpi stained for GrB
(green) and CD3 (red), showing co-localization of GrB and CD3 (arrow).
a, c Open and filled symbols refer to ganglia from individual animals
infected with SVV-EGFP (n= 3) or SVV-wt (n = 2), respectively. b, d
Nuclei were counterstained with DAPI. Magnification ×400 and ×2.0
digital zoom. Statistical analysis was performed using the Student’s t test
(a) and Pearson’s correlation test (c)
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CD68 and MHC-II and for the proliferation marker Ki67. SGC
expressed very low levels of CD68 and modest amounts of
MHC-II at 9 dpi, while both CD68 and MHC-II were more
highly expressed at 20 dpi and especially at 13 dpi compared
to 9 dpi (Fig. 5a). Increased numbers of Ki67+ cells were detect-
ed at 13 and 20 dpi compared to 9 dpi (Fig. 5a). Notably, most
Ki67+ were S100B+ SGC and infiltrating CD3+ Tcells (Fig. 5b,
c). The number and location of IHC-positive SGC and CD3+ T
ce l l s were not d i ffe ren t be tween SVV-wt - and
SVV-EGFP-infected animals (data not shown). Overall, these
results suggest an active role for SGC in the ganglionic immune
response following primary SVV infection.
Discussion
The role of the immune response in ganglia after varicella is
largely unknown. Ganglia obtained from varicella patients
show limited histopathological changes, suggesting control
of virus replication (Berg et al. 1969; Cheatham et al. 1956;
Nagashima et al. 1975). Primary SVV infection induces an
analogous minor histopathology and mild inflammation in
ganglia of AGM (Ouwendijk et al. 2013b). Our current study
aim to further characterize the immune response in ganglia
after acute SVV infection reports two main findings.
Primary SVV infection induces (1) a transient increase in
CD8dim and CD8bright memory Tcells and (2) local expression
of the chemokine CXCL10 and activation/proliferation of
both resident neuron-interacting SGC and infiltrating T cells
in ganglia.
SVV enters ganglia at 6 dpi, ganglionic viral DNA loads
peak at 9 dpi, and SVV latency is probably established from 3
to 10 weeks after infection (Mahalingam et al. 2001;
Messaoudi et al. 2009; Ouwendijk et al. 2012, 2013b). The
significantly higher SVV DNA load and more abundant SVV
nucleocapsid antigen expression in ganglia at 9 dpi compared
to 13 and 20 dpi (Ouwendijk et al. 2013b) suggest an initial
phase of virus replication followed by establishment of laten-
cy. This is supported by the detection immediate-early, early,
and late transcripts in ganglia during acute SVV infection
(Nagel et al. 2013; Ou et al. 2007), which contrasts the re-
stricted viral gene expression detected in SVV latently infect-
ed ganglia (Messaoudi et al. 2009; Ouwendijk et al. 2012).
The decline in SVV DNA load in ganglia parallels the recov-
ery from skin rash and emergence of systemic humoral and
cell-mediated anti-SVV responses (Haberthur et al. 2011;
Messaoudi et al. 2009; Ouwendijk et al. 2012). Herein, we
show that a reduction in viral load in ganglia at 9 to 13 dpi
(Ouwendijk et al. 2013b) (Table 1) is accompanied by an
influx of CD8dim and CD8bright memory T cells. Specific en-
richment of CD8dim T cells, which develop from CD4+ T cells
and recognize antigen presented by MHC-II molecules
(Beaumier et al. 2009), and increased MHC-II expression on
SGC suggest a critical role for MHC-II-restricted T cell re-
sponses. Indeed, depletion of CD4+ T cells, but not CD8+ T
cells or B cells, during primary SVV infection resulted in
sustained lytic viral gene expression in ganglia (Meyer et al.
2013). Overall, the data suggest that Tcells infiltrating ganglia
contribute to the control of SVV replication and potentially to
the establishment of latency.
The increased number of T cells in ganglia after primary
SVV infection might reflect recruitment of T cells via expres-
sion of chemokines such as CXCL10, followed by local pro-
liferation of T cells. Limited numbers of Ki67+-proliferating T
cells were detected in ganglia at 13 and 20 dpi. T cell prolif-
eration might be induced by infiltrating CD11c+ myeloid cells
or activated SGC (Wakim et al. 2008). Additionally, we show
that primary SVV infection induces CXCL10 expression in
neurons, SGC, and infiltrating lymphocytes. The chemokine
CXCL10 (interferon-inducible protein-10) is secreted by a
variety of cell types in response to type I and II interferons
and orchestrates migration of CXCR3-bearing activatedmem-
ory T cells and natural killer cells into tissues (Loetscher et al.
1996; Luster et al. 1985; Sallusto et al. 1998; Zlotnik and
Yoshie 2012). Previous studies suggest the prime role of
Fig. 4 Chemokine CXCL10 expression in ganglia after primary SVV
infection of African green monkeys. Ganglia (n = 32) obtained from
SVV-wt- (n= 2) and SVV-EGFP-infected animals (n= 3) were analyzed
for CXCL10 transcript expression by in situ hybridization (ISH) using
FastRed as a substrate (pink) and nuclei counterstained with hematoxylin
(blue) (see Table 1). a CXCL10 was detected in both neurons (left panel)
and non-neuronal cells (right panel). Left panel sacral ganglion obtained
at 13 dpi from a SVV-wt-infected AGM (animal 273). Right panel tho-
racic ganglion obtained at 9 dpi from a SVV-wt-infected AGM (animal
269). Magnification ×400. b Ratio of neurons and non-neuronal cells
expressing CXCL10 transcripts normalized to the number of neurons in
the same section. c, d Scatter plots of the ratio of CXCL10+ neurons/total
number of neurons versus the ratio of granzyme B (GrB)+ cells/neurons
(c) and ratio of CD3+ cells/neurons (d) in the same ganglia. Average
values per anatomic level of the neuraxis are plotted. e Ganglia were
analyzed for SVV ORF63 transcript expression by ISH showing occa-
sional ORF63+ non-neuronal cells (left panel) andORF63+ neurons (right
panel). Left panel cervical ganglion obtained at 13 dpi from a SVV-wt-
infected AGM (animal 279). Right panel thoracic ganglion obtained at
9 dpi from a SVV-wt-infected AGM (animal 269). Arrows indicate neu-
rons expressing (peri-)nuclear ORF63 transcripts. Arrowheads indicate
neurons expressing cytoplasmatic and (peri-)nuclear ORF63 transcripts.
Magnification ×400. f Ratio of SVV ORF63 transcript positive non-
neuronal cells normalized to the number of neurons in the same section.
g Frequency of SVV ORF63 transcript positive neurons. h Scatter plot of
the ratio of ORF63+ neurons/total number of neurons versus the ratio of
CXCL10+ neurons/total number of neurons in the same ganglia. i Repre-
sentative images of adjacent sections from ganglia obtained at 13 dpi
from the SVV-wt-infected animal 279 were stained for SVV ORF63
transcripts and CXCL10 transcripts by ISH. Magnification ×400. Arrows
indicate examples of SVV ORF63+ neurons. Asterisks indicate the same
neurons in adjacent sections. b, c, d, f, g Open and filled symbols refer to
ganglia from individual animals infected with SVV-EGFP or SVV-wt,
respectively (Table 1). b, f Individual ganglia are shown, and horizontal
bars indicate mean values. Statistical analysis was performed using the
Student’s t test (b, e) and Pearson’s correlation test (c, d, f). *p< 0.05
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neuronal CXCL10 production in recruitment of T cells in re-
sponse to neurotropic viral infection such as rabies virus and
West Nile virus (Chai et al. 2015; Klein et al. 2005). Similarly,
the current study showed that neuronal CXCL10 expression
correlated significantly with activated GrB+ Tcells infiltrating
ganglia and to a limited extent with the total number of Tcells.
Whereas SVV-specific T cells are already detected in blood at
7 dpi (Haberthur et al. 2011; Messaoudi et al. 2009;
Ouwendijk et al. 2012), additional studies are warranted to
demonstrate the antigen specificity of T cells in ganglia after
primary SVV infection.
Neuronal CXCL10 expression is associated with acute vi-
rus replication in ganglia, while (infiltrating) non-neuronal
cells may produce CXCL10 for extended periods after cessa-
tion of virus replication (Ouwendijk et al. 2013a; Steain et al.
2011; Theil et al. 2003). Our demonstration of induction of
CXCL10 expression in neurons after primary SVVinfection is
similar to earlier observations of active VZV replication, both
in ganglia explants infected with VZV in vitro and in ganglia
obtained at autopsy from zoster patients (Steain et al. 2011). In
contrast, CXCL10 transcripts were found only in
non-neuronal cells in ganglia >1 week after SVV reactivation
Fig. 5 Increased expressions of activation and proliferation markers on
satellite glial cells in ganglia after primary SVVinfection of African green
monkeys. a Immunohistochemical (IHC) staining of ganglia (n= 72 gan-
glia from five animals; see Table 1) at 9, 13, and 20 days post-infection
(dpi) using CD68, MHC-II, and Ki67 markers. Representative IHC im-
ages are shown for 9 dpi [CD68, MHC-II, and Ki67, cervical ganglion
from animal 269 (SVV-wt)], 13 dpi [CD68, sacral ganglion from animal
273 (SVV-EGFP); MHC-II and Ki67, sacral ganglion from animal 279
(SVV-wt)], and 20 dpi [CD68, MHC-II, and Ki67, sacral ganglion from
animal 283 (SVV-EGFP)]. b Representative confocal microscopy image
of a section of ganglia obtained at 13 dpi from SVV-wt-infected animal
279 stained for Ki67 (red) and S100B (green). Nuclei were counter-
stained with DAPI. Arrow indicates Ki67+ S100B+ SGC. c Examples of
adjacent sections of sacral ganglia obtained from the SVV-EGFP-infected
animal 273 at 13 dpi were stained by IHC for Ki67 and CD3. a, c Staining
was visualized using 3-amino-9-ethylcarbazole as a substrate (red). All
sections were stained in the same experiment, and nuclei were counter-
stained with hematoxylin (blue). a–cMagnification ×400
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and in HSV-1 latently infected human trigeminal ganglia
(Ouwendijk et al. 2013a; Theil et al. 2003). Herein, we
showed that SVV ORF63 transcripts correlated with
CXCL10 RNA in neurons. However, neither neuronal nor
non-neuronal CXCL10 expression co-localized with
SVV-infected neurons, suggesting that SVV infection im-
paired CXCL10 expression or, more l ikely, that
SVV-infected neurons and/or infiltrating lymphocytes secrete
CXCL10-inducing factors. Potent inducers of CXCL10 in-
clude type I and II interferons that signal via signal transducers
and activators of transcription 1 (STAT1) (Loetscher et al.
1996; Luster et al. 1985; Zlotnik and Yoshie 2012).
However, only rare neurons, SGC, and infiltrating cells
stained for nuclear phosphorylated STAT1 (data not shown),
suggesting that other cytokines or chemokines are involved
(Dong et al. 2013).
Innate ganglionic immune responses are sufficient to con-
trol virus replication and establishment of VZV latency in an
experimental chimeric mouse model of VZV infection
(Zerboni et al. 2005). SGC can produce inflammatory media-
tors, such as prostaglandins, tumor necrosis factor (TNF)-α,
and interleukin (IL)-6 and IL-15, and can modulate local Tcell
function (Hanani 2005; van Velzen et al. 2009). HSV-1 infec-
tion of mice increases MHC-I and MHC-II expressions on
SGC, causes SGC proliferation, and induces TNF-α and
IL-6 production in SGC surrounding HSV-infected neurons
(Elson et al. 2003; Mori et al. 2003; Pereira et al. 1994;
Shimeld et al. 1999). Similarly, we find that primary SVV
infection causes increased CD68 and MHC-II expressions
on SGC and, possibly, restricted SGC proliferation in ganglia
along the entire neuraxis. Together, the data suggest an active
role for SGC in the ganglionic immune response following
alphaherpesvirus infection.
SVV-EGFP was attenuated compared to SVV-wt
(Ouwendijk et al. 2013b), as shown by the reduced viral
DNA load in ganglia and lower number of neurons expressing
SVV ORF63 transcripts in SVV-EGFP- compared to
SVV-wt-infected AGMs (Table 1 and Fig. 4b). Nevertheless,
ganglia obtained from both SVV-wt- and SVV-EGFP-infected
AGMs showed broad activation of SGC and increased num-
bers of CD3+ T cells and CD11c+ myeloid cells. By contrast,
neuronal CXCL10 expression and the associated number of
GrB+ T cells (Fig. 4c) were significantly increased in
SVV-wt-infected AGM, consistent with the observed correla-
tion between SVV ORF63 RNA and CXCL10 transcript ex-
pression in neurons (Fig. 4g). Collectively, the data suggest
that primary SVV infection induces a similar number of im-
mune infiltrates independent of viral load and the SVV virus
(SVV-wt and SVV-EGFP) used. Notably, the expressions of
immune effector molecules (granzyme B and CXCL10) did
correlate with viral load.
In conclusion, the emergence of local immune responses
coincided with the decline in viral DNA load in ganglia,
suggesting that intra-ganglionic immunity contributes to
restricting local SVV infection. These data implicate a multi-
faceted immune response in ganglia after primary SVV infec-
tion involving neurons, SGC, and infiltrating CD11c+myeloid
cells and Tcells. Further studies in larger cohorts are needed to
conclusively define the cell types and mediators that control
virus replication in ganglia and establishment of SVV latency.
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